KMTS
Kestra Medical Technologies, Ltd.
27.40$
+1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 21 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -11.1% | +173.8% | -10.0% | -7.4% | +53.8% | -5.5% | -3.1% | |
| – | – | – | – | – | -20.5% | +265.2% | -13.6% | -11.5% | +60.7% | -29.2% | +1.8% | |
| – | – | – | – | – | -29.3% | +337.1% | -15.3% | -12.8% | +66.1% | -65.8% | -31.2% | |
| – | – | – | – | – | -29.3% | +337.1% | -15.3% | -12.8% | +66.1% | -32.6% | +1.3% | |
| – | – | – | – | – | +47.0% | +1.9% | +14.4% | +12.6% | +22.0% | +14.4% | +5.9% | |
| – | – | – | – | – | +38.8% | +9.6% | +3.5% | +1.7% | -1.3% | -1.8% | +10.9% | |
| – | – | – | – | – | +2.2% | -75.3% | -9.1% | +0.6% | +10.6% | +8.2% | +26.5% | |
| – | – | – | – | – | +23.6% | -1.9% | -15.1% | +10.9% | +20.1% | +17.3% | -4.2% | |
| – | – | – | – | – | – | – | -80.7% | +47.2% | -81.1% | +210.0% | -25.8% | |
| – | – | – | – | – | +27.0% | -6.6% | -22.5% | +8.8% | +18.9% | +13.6% | -4.9% | |
| – | – | – | – | – | +0.9% | -6.1% | +0.9% | +0.9% | +0.9% | +0.9% | +70.0% | |
| – | – | – | – | – | – | – | -10.3% | -10.9% | +75.5% | -9.8% | -14.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +3.6% | +0.1% | +2.9% | +10.5% | +0.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.